Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

CD70 expression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

CD70 expression	Uterine Corpus Leiomyosarcoma	CD70 expression	Uterine Corpus Leiomyosarcoma	JNJ-0631 Sensitive: C3 – Early Trials JNJ-0631 Sensitive : C3	JNJ-0631 Sensitive: C3 – Early Trials JNJ-0631 Sensitive : C3
CD70 expression	Cutaneous T-cell Lymphoma	CD70 expression	Cutaneous T-cell Lymphoma	ARGX-110 Sensitive: C3 – Early Trials ARGX-110 Sensitive : C3	ARGX-110 Sensitive: C3 – Early Trials ARGX-110 Sensitive : C3
CD70 expression	Acute Myelogenous Leukemia	CD70 expression	Acute Myelogenous Leukemia	ALLO-316 Sensitive: D – Preclinical ALLO-316 Sensitive : D	ALLO-316 Sensitive: D – Preclinical ALLO-316 Sensitive : D
CD70 expression	Acute Myelogenous Leukemia	CD70 expression	Acute Myelogenous Leukemia	venetoclax + ARGX-110 Sensitive: D – Preclinical venetoclax + ARGX-110 Sensitive : D	venetoclax + ARGX-110 Sensitive: D – Preclinical venetoclax + ARGX-110 Sensitive : D
CD70 expression	Renal Cell Carcinoma	CD70 expression	Renal Cell Carcinoma	ALLO-316 Sensitive: D – Preclinical ALLO-316 Sensitive : D	ALLO-316 Sensitive: D – Preclinical ALLO-316 Sensitive : D
CD70 expression	B Acute Lymphoblastic Leukemia	CD70 expression	B Acute Lymphoblastic Leukemia	CD70-targeted CAR-T immunotherapy Sensitive: D – Preclinical CD70-targeted CAR-T immunotherapy Sensitive : D	CD70-targeted CAR-T immunotherapy Sensitive: D – Preclinical CD70-targeted CAR-T immunotherapy Sensitive : D
CD70 expression	Solid Tumor	CD70 expression	Solid Tumor	CAT-248 Sensitive: D – Preclinical CAT-248 Sensitive : D	CAT-248 Sensitive: D – Preclinical CAT-248 Sensitive : D